Amy graduated with a BSc (Hons) in Medical Biochemistry from the University of Birmingham in the UK in 2000. Following this she then obtained her PhD in Immunogenetics from Imperial College London in 2005. Amy is currently a Senior Research Associate in the Musculoskeletal Research Group at Newcastle University. Her area of interest is understanding disease pathogenesis in rheumatoid arthritis for application to both biomarker discovery and the development of novel immunotherapies for tolerance induction. She is involved in numerous clinical studies, including BIO-FLARE which aims to understand the biological factors driving disease flare in rheumatoid arthritis, as well as AuToDeCRA2, a phase II clinical trial using autologous tolerogenic dendritic cells for the treatment of rheumatoid arthritis.